Saxenda, Wegovy, and Zepbound patients are included regardless of obesity diagnostic claims
It prescribes outside standard BMI thresholds and shares a physician network with sister brand Winona, giving it real hormone-therapy continuity for the roughly 70%-women, average-age-44 audience this drug serves
Monitoring of clotting parameters may be required during treatment
Side Effects: The Critical Difference Melanotan-1 Side Effects MT-1's selective MC1R binding means a very clean side effect profile: Mild facial flushing (most common, transient) Slight nausea (rare at standard doses) Injection site redness (minor, fades quickly) Headache (uncommon) In clinical trials for EPP, serious adverse events were rare and MT-1 was generally well tolerated over extended use periods (Langendonk et al., 2015)
No, we prevent cloudiness through quality control & assurance